characteristics.text: SAMN47560497
characteristics.characteristic: External Id
characteristics.text: Kyoto University Graduate School of Medicine
characteristics.characteristic: INSDC center name
characteristics.text: 2025-12-15T00:41:35.830Z
characteristics.characteristic: INSDC first public
characteristics.text: 2025-12-15T00:41:35.830Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS24484432
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Human
characteristics.characteristic: NCBI submission model
characteristics.text: Human.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS24484432
characteristics.characteristic: SRA accession
characteristics.text: missing
characteristics.characteristic: age
characteristics.text: Dr. A. Santin, Yale University, New Haven, CT, USA
characteristics.characteristic: biomaterial_provider
characteristics.text: ARK1
characteristics.characteristic: cell_line
characteristics.text: serous endometrial carcinoma cell
characteristics.characteristic: cell_subtype
characteristics.text: cancer cell
characteristics.characteristic: cell_type
characteristics.text: 2022-10
characteristics.characteristic: collection_date
characteristics.text: not applicable
characteristics.characteristic: culture_collection
characteristics.text: Uterine serous carcinoma cell line xenograft model. Tumors were subcutaneously implanted into NOD/SCID mice and treated with vehicle control. Total RNA was extracted 6 hours after the final dose.
characteristics.characteristic: description
characteristics.text: adult
characteristics.characteristic: dev_stage
characteristics.text: Uterine serous carcinoma
characteristics.characteristic: disease
characteristics.text: FIGO stage IVB
characteristics.characteristic: disease_stage
characteristics.text: Caucasian
characteristics.characteristic: ethnicity
characteristics.text: unknown
characteristics.characteristic: genotype
characteristics.text: missing
characteristics.characteristic: geo_loc_name
characteristics.text: diseased
characteristics.characteristic: health_state
characteristics.text: missing
characteristics.characteristic: isolate
characteristics.text: abnormal
characteristics.characteristic: karyotype
characteristics.text: total RNA
characteristics.characteristic: molecule
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: Uterine serous carcinoma
characteristics.characteristic: phenotype
characteristics.text: not applicable
characteristics.characteristic: population
characteristics.text: Caucasian
characteristics.characteristic: race
characteristics.text: ARK1_control rep4
characteristics.characteristic: replicate_id
characteristics.text: cancer cell line
characteristics.characteristic: sample_type
characteristics.text: female
characteristics.characteristic: sex
characteristics.text: Endometrium
characteristics.characteristic: tissue
characteristics.text: ARK1 cells_control_4
characteristics.characteristic: title
characteristics.text: vehicle (DMSO, same dosage as CTX-439 group)
characteristics.characteristic: treatment